1-4 of 4
Bastianella Perazzona, Ph.D.
Close
Sort by
Journal Articles

K562-R As a Model to Study Jak2 in a Non Bcr-Abl Addicted Cell Line

Bastianella Perazzona, Ph.D., Yu-Hsi Lin, Ralph B. Arlinghaus, PhD
Journal: Blood
Blood (2011) 118 (21): 4412.
https://doi.org/10.1182/blood.V118.21.4412.4412
Published: 2011
Journal Articles

BCR-ABL1 Kinase Activity but Not Its Expression Is Dispensable for Ph+ Quiescent Stem Cell Survival Which Depends on the PP2A-Controlled Jak2 Activation and Is Sensitive to FTY720 Treatment

Paolo Neviani, Ph.D, Jason G Harb, Ph.D, Joshua J Oaks, B.S., Christopher Walker, B.S., Ramasamy Santhanam, Ph.D, Carolyn Paisie, B.S., Anna Eiring, Ph.D, Bin Zhang, Ph.D, Bastianella Perazzona, Ph.D, Y. Ma, Charlene Mao, Guido Marcucci, MD, Tessa L. Holyoake, PhD, FRCP, FRCPath, Stefano Volinia, MD, Jorge E. Cortes, MD, Michael A. Caligiuri, MD, Claudia Huettner, Ph.D, Robert Bittman, Ph.D, Ching-Shih Chen, Ph.D, Ralph B. Arlinghaus, PhD, Peter Hokland, MD, DMSC, Denis-Claude Roy, MD, FRCPC, Ravi Bhatia, MD, Danilo Perrotti, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 515.
https://doi.org/10.1182/blood.V116.21.515.515
Published: 2010
Journal Articles

Jak2 Regulates Bcr-Abl In CD34+ Cells From Imatinib Mesylate-Resistant CML Patients.

Ajoy K. Samanta, Ph.D., Bastianella Perazzona, Ph.D., Sandip N. Chakraborty, Xiaoping Sun, MD, PhD, Hardik Modi, Ravi Bhatia, MD, Ralph B. Arlinghaus, PhD
Journal: Blood
Blood (2010) 116 (21): 1220.
https://doi.org/10.1182/blood.V116.21.1220.1220
Published: 2010
Journal Articles

Role of BCR in Down-Modulation of BCR-ABL Oncogenicity in CML

Bastianella Perazzona, Ph.D., Yan Wang, M.D., Ralph B. Arlinghaus, PhD
Journal: Blood
Blood (2008) 112 (11): 3210.
https://doi.org/10.1182/blood.V112.11.3210.3210
Published: 2008